(Q35030577)

5 August 2017

1 reference

title

Current issues regarding the use of drotrecogin alfa (activated). (English)

1 reference

5 August 2017

1 reference

Erkan Hassan

1

1 reference

5 August 2017

Henry J Mann

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

22

1 reference

5 August 2017

issue

12 Pt 2

1 reference

5 August 2017

page(s)

206S-215S

1 reference

Efficacy and safety of recombinant human activated protein C for severe sepsis

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.206S.33707

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.206S.33707

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.206S.33707

Randomized, controlled clinical trials in sepsis: has methodological quality improved over time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.18.206S.33707

10.1592/PHCO.22.18.206S.33707

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference